RB1 and benign smooth muscle neoplasm: This differential diagnosis is critical and extends to uterine leiomyosarcoma, where immunohistochemical panels (e.g., for p53, RB1, ATRX, PTEN) have shown utility in distinguishing malignant from benign smooth muscle tumors [27].